Lo En Ox
This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA
Overview
Download & View Lo En Ox as PDF for free.
More details
- Words: 329
- Pages: 3
NURS 1566 Clinical Form 3: Clinical Medications Worksheets (You will need to make additional copies of these forms) Generic Name Enoxaparin Peak Unknown
Trade Name Lovenox Onset Unknown
Classification Dose Route Time/frequency Low molecular 40 mg SQ Daily weight heparins Duration Normal dosage range Medical patients with acute illness--40 mg once daily 12 hrs
Why is your patient getting this medication Prevention of DVT/Pulmonary Embolism
For IV meds, compatibility with IV drips and/or solutions N/A
Mechanism of action and indications (Why med ordered) Potentiates the inhibitory effect of antithrombin on factor Xa and thrombin. Indicated for prevention and treatment of DVT and Pulmonary Embolism
Nursing Implications (what to focus on) Contraindications/warnings/interactions . Contraindicated in: • H yper sens itivi ty
• H yper sens itivi ty to ben zyl alco hol (mu ltido se vial)
• Posi tive in vitr o test for anti plat elet anti bod y in the pres ence of eno xap arin
• Acti ve, maj or
Use Cautiously in:
Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) None for this patient
Lab value alterations caused by medicine Monitor CBC, platelet count, and stools for occult blood periodically during therapy. If thrombocytopenia occurs, monitor closely. If hematocrit decreases unexpectedly, assess patient for potential bleeding sites
Be sure to teach the patient the following about this medication Advise patient to report any symptoms of unusual bleeding or bruising, dizziness, itching, rash, fever, swelling, or difficulty breathing to health care professional immediately
Nursing Process- Assessment (Pre-administration assessment) Assess for abnormal bleeding and monitor aPTT. Assess for signs of bleeding and hemorrhage (bleeding gums; nosebleed; unusual bruising; black, tarry stools; hematuria; fall in hematocrit or blood pressure; guaiac-positive stools); bleeding from surgical site. Notify physician or other health care professional if these occur
Assessment Why would you hold or not give this med? If signs of bleeding and hemorrhage are present.
Evaluation Check after giving Signs of bleeding and hemorrhage and aPTT levels.
Trade Name Lovenox Onset Unknown
Classification Dose Route Time/frequency Low molecular 40 mg SQ Daily weight heparins Duration Normal dosage range Medical patients with acute illness--40 mg once daily 12 hrs
Why is your patient getting this medication Prevention of DVT/Pulmonary Embolism
For IV meds, compatibility with IV drips and/or solutions N/A
Mechanism of action and indications (Why med ordered) Potentiates the inhibitory effect of antithrombin on factor Xa and thrombin. Indicated for prevention and treatment of DVT and Pulmonary Embolism
Nursing Implications (what to focus on) Contraindications/warnings/interactions . Contraindicated in: • H yper sens itivi ty
• H yper sens itivi ty to ben zyl alco hol (mu ltido se vial)
• Posi tive in vitr o test for anti plat elet anti bod y in the pres ence of eno xap arin
• Acti ve, maj or
Use Cautiously in:
Interactions with other patient drugs, OTC or herbal medicines (ask patient specifically) None for this patient
Lab value alterations caused by medicine Monitor CBC, platelet count, and stools for occult blood periodically during therapy. If thrombocytopenia occurs, monitor closely. If hematocrit decreases unexpectedly, assess patient for potential bleeding sites
Be sure to teach the patient the following about this medication Advise patient to report any symptoms of unusual bleeding or bruising, dizziness, itching, rash, fever, swelling, or difficulty breathing to health care professional immediately
Nursing Process- Assessment (Pre-administration assessment) Assess for abnormal bleeding and monitor aPTT. Assess for signs of bleeding and hemorrhage (bleeding gums; nosebleed; unusual bruising; black, tarry stools; hematuria; fall in hematocrit or blood pressure; guaiac-positive stools); bleeding from surgical site. Notify physician or other health care professional if these occur
Assessment Why would you hold or not give this med? If signs of bleeding and hemorrhage are present.
Evaluation Check after giving Signs of bleeding and hemorrhage and aPTT levels.
Related Documents
Lo En Ox
November 2019 23
En Ox A Par In
November 2019 11
Ox-introduction
November 2019 19
Lo Lo Lo Lo
December 2019 84
Salmon Ox
November 2019 15
